Our study therefore aimed to identify the associations between CSF Aß42 and Tau protein levels with regional brain volumes and then to evaluate the optimal use of each of these markers in predicting impairments on neuropsychological examination among participants in a brain aging study ranging from cognitively healthy (CH) to AD. Here, MAPT is linked to Alzheimer disease.